U.S. Medical Equipment Stock News

Travelers Companies expansion and recent bond issuance Travelers Companies (TRV) recently completed the nationwide rollout of its Travelers Synergy product liability coverage for life sciences firms, while also issuing callable senior unsecured fixed rate notes due 2031 totaling about US$750 million. See our latest analysis for Travelers Companies. At a share price of US$374.36, Travelers Companies has had a mixed few days, with the 1-day share price return declining 0.43% and the 7-day share...

In late July 2026, Wave Life Sciences reported Q2 2026 results showing sales of US$2.27 million versus US$8.70 million a year earlier, with net loss widening to US$69.36 million and basic loss per share from continuing operations at US$0.34. Despite weaker quarterly revenue, the company highlighted progress in its RNAi and RNA editing programs, including positive data for obesity candidate WVE-007 and preparations for an FDA meeting on a potential accelerated approval pathway for AATD...

International Seaways stock has logged very strong returns over the past few years, and after that run the current checks suggest it no longer looks obviously cheap on valuation. Over the last 5 years, International Seaways has delivered a very large total return of about 8.6x, which sets a high bar for any further share price gains to be justified by fundamentals. Future cash flows and earnings can benefit if the company maintains capital discipline and steady fleet utilization, while any...

In the second quarter of 2026, Axogen reported sales of US$69.73 million, up from US$56.66 million a year earlier, but moved from a net income of US$0.579 million to a net loss of US$1.52 million, with both basic and diluted loss per share from continuing operations at US$0.03. Despite higher losses for both the quarter and first half of 2026, Axogen raised its full-year 2026 revenue guidance to at least US$279 million, highlighting management’s increased confidence in the company’s top-line...

Revolution Medicines (RVMD) is back in focus after the FDA accepted its New Drug Application for daraxonrasib in previously treated metastatic pancreatic ductal adenocarcinoma, following Phase 3 RASolute 302 survival and quality of life data. See our latest analysis for Revolution Medicines. At a share price of US$187.53, Revolution Medicines has seen the share price rise 34.45% over the past 90 days and 137.32% year to date, with a 1 year total shareholder return above 400%. This suggests...

Grand Canyon Education, Inc. has already reported second-quarter 2026 results showing higher net income of US$45.85 million and diluted EPS of US$1.75, alongside updated guidance calling for full-year 2026 diluted EPS between US$9.93 and US$10.07. An interesting angle is management’s expectation that reduced annual service revenue under a revised Grand Canyon University agreement will have only an immaterial effect on operating income, even as hybrid enrollment grows strongly. Next, we’ll...

Dorchester Minerals, L.P. previously announced a second quarter 2026 cash distribution of US$1.272943 per common unit for activity through June 30, 2026, payable on August 13, 2026 to unitholders of record as of August 3, 2026. This relatively high quarterly payout underscores the partnership’s ongoing importance for investors who prioritize regular cash distributions from energy-related assets. Against this backdrop, we’ll explore how Dorchester Minerals’ latest cash distribution shapes its...

In recent weeks, Michael Burry increased his position in Zoetis, reflecting his preference for consumer and healthcare names over the AI-focused semiconductor sector. This portfolio shift draws fresh attention to Zoetis’ role as a pure-play animal health company, potentially highlighting its differentiated exposure versus high-profile technology trades. We’ll now explore how Burry’s increased stake interacts with Zoetis’ existing animal health growth thesis and affects its broader investment...

Earlier this week, U.S.-based fintech startup 1TCH launched a unified global payments and professional work management platform aimed at freelancers, remote teams, startups, and international businesses, putting it in direct competition with BILL Holdings’ core customer segments. The move challenges BILL’s integrated financial operations offering by combining banking, invoicing, and project management in a single system that directly targets the same workflow pain points. Next, we’ll examine...

Coty (COTY) stock recently drew attention after recent trading saw the share price at US$2.75, with investors weighing its mixed return profile and the latest available financial figures for the beauty group. See our latest analysis for Coty. Recent trading has given Coty some short term momentum, with a 1 month share price return of 20.61% and a 3 month gain of 11.34%. However, the year to date share price return is still down 11.58% and the 1 year total shareholder return has declined...

Political risk is front and center again as the Senate stand-off over Trump’s attorney general nomination and talk of reviving a US$1.8b anti weaponisation fund stir questions about future legal and regulatory priorities. That mix of uncertainty and potential spending can ripple into US Defense & Security Sector stocks that work in defense, cybersecurity, investigations, legal services, and government contracting. This article walks through 3 stocks that appear positively exposed to the...

XPEL (XPEL) recently announced an approximately $110 million investment to expand its manufacturing and supply chain footprint, including a new specialized production facility in China and additional domestic capacity. See our latest analysis for XPEL. At a share price of $44.37, XPEL has seen short term share price pressure, with the 30 day share price return down 9.3% and the 90 day share price return down 7.18%. At the same time, the 1 year total shareholder return is 40.9%, which points...

In late July 2026, GlobalFoundries Inc. disclosed that director Elissa Murphy resigned from all Board roles and, alongside the previously announced departure of Martin L. Edelman, reduced the Board size from thirteen to eleven members, while also confirming her exit was not due to any disagreement with the company. The company also entered into a letter of intent with the U.S. Department of Commerce for a US$300 million CHIPS Act-funded push into next-generation silicon photonics and...

Republic Services, Inc. previously announced it would pay a quarterly dividend of US$0.6700 per share on October 15, 2026, to shareholders of record as of the ex-dividend and record date on October 2, 2026. Alongside this dividend update, investors are focusing on the company’s 2025 Sustainability Report and polymer recycling initiatives, which highlight its push into higher-value circular plastics and decarbonization services. Next, we’ll examine how Republic Services’ expanding Polymer...

In the second quarter of 2026, Rogers Corporation reported higher sales of US$216.8 million and returned to profitability with US$13.6 million in net income, while also completing a long-running share repurchase program totaling 2,150,609 shares for US$150.44 million. This combination of improved earnings, guidance for third-quarter net sales of US$233 million to US$243 million, and a substantial multi-year buyback completion highlights management’s focus on both operational performance and...

Edison International stock has delivered a 68.8% return over the past five years, yet the latest valuation checks still point to shares looking relatively cheap after that run. Recent headlines around wildfire liability and potential pressure on credit ratings now sit alongside this stronger long term share performance and raise fresh questions about how much risk is already reflected in the current price. A 68.8% return over five years signals that long term holders in Edison International...

SLB (NYSE:SLB) stock is in focus after the company paired second quarter results with fresh guidance that points to continued global revenue growth in the second half of 2026. See our latest analysis for SLB. SLB shares have been choppy around the latest earnings and guidance, with a 1-day share price return of 1.39% and a 30-day share price return of 9.98%, but the 90-day share price return is down 12.88%. Over a longer horizon, momentum still looks constructive, with a year to date share...

Wingstop Inc. recently reported second-quarter 2026 results showing higher revenue of US$185.56 million and net income of US$31.29 million, while also declaring a quarterly dividend of US$0.33 per share to be paid on September 5, 2026. However, the company’s updated 2026 outlook calling for a 4% to 6% decline in domestic same-store sales growth contrasts with its quarterly earnings progress and raises questions about the durability of its recent operating momentum. We’ll now examine how the...

In late July 2026, Illinois Tool Works Inc. reported second-quarter sales of US$4,301 million and net income of US$815 million, with both basic and diluted EPS from continuing operations increasing compared with a year earlier, and also repurchased 2,891,937 shares for US$750 million as part of its ongoing buyback program. The company also raised its full-year 2026 guidance, lifting expected GAAP EPS to US$11.35–US$11.55, projecting operating margins of 26.5%–27.5%, and modestly higher...

Cooling signals from the Federal Reserve’s preferred inflation gauges are starting to reshape the risk and reward balance for consumer and retail stocks. Trimmed mean measures now sit near multi year lows, while headline inflation still runs above the Fed’s 2% target and some officials keep warning about sticky price pressures. That mix can benefit companies that rely on steady consumer demand, and it can pressure stocks that have leaned on aggressive price increases. This article looks at...

PROCEPT BioRobotics (PRCT) is back in focus after a fresh class action filing that challenges its past sales practices, inventory levels, and financial disclosures. This development is putting legal risks and business transparency under closer investor scrutiny. See our latest analysis for PROCEPT BioRobotics. The latest legal filing lands after a tough stretch for PROCEPT BioRobotics shareholders. The stock closed at US$18.62, with a 7 day share price return of 11.56% that follows a 30 day...

U.S. Physical Therapy stock has climbed 15.8% over the past year, but investors who have held it for three years are still facing a loss of about 29.3%. The latest valuation checks suggest the shares lean expensive on market multiples rather than offering an obvious bargain. Over the past three years, U.S. Physical Therapy has delivered a total return that is down 29.3%, which raises questions about how much of a recovery is already reflected in today’s share price. Future growth in patient...

Highwoods Properties (HIW) is back in focus after reporting second quarter 2026 earnings, with sales of US$216.38 million and net income of US$94.05 million, alongside higher earnings per share versus a year earlier. See our latest analysis for Highwoods Properties. The latest earnings jump and affirmed dividend have come against a backdrop of stronger price momentum for Highwoods Properties, with the 90 day share price return of 35.45% and a 3 year total shareholder return of 69.16% pointing...

In the past few weeks, Primoris Services Corporation has been hit with multiple securities class action lawsuits alleging it misled investors about project management, cost estimation, and profitability in its renewables business, following disclosures of project delays, higher costs, margin pressure, and key executive departures including the President of Renewables and the COO. An important implication is that alleged weaknesses in overseeing fixed-price renewable energy projects raise...